)
Visual21 Nov 2025
Data center suppliers
Fennec Pharmaceuticals (FENC) investor relations material
Fennec Pharmaceuticals Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Achieved record net product sales of $12.5 million in Q3 2025, a 79% year-over-year increase, marking the highest quarterly sales to date and the first profitable quarter from operations.
PEDMARK® adoption accelerated within major oncology networks, with increased focus on adolescent and young adult (AYA) populations and four consecutive quarters of double-digit growth.
Cash and cash equivalents rose to $21.9 million as of September 30, 2025, up from $18.7 million at the end of Q2 2025, reflecting positive cash flow from operations.
Continued clinical data generation and engagement with key opinion leaders; preliminary results from the Japan STS-J01 clinical trial expected in Q4 2025.
Financial highlights
Q3 2025 net product sales: $12.5 million, up from $7.0 million in Q3 2024.
Nine months ended September 30, 2025: net product sales of $30.9 million, up from $21.7 million in the same period of 2024.
Q3 2025 net loss: $0.6 million, a significant improvement from $5.7 million net loss in Q3 2024; net loss narrowed to $(0.02) per share (basic and diluted) in Q3 2025.
Selling and marketing expenses in Q3 2025: $5.2 million; general and administrative expenses: $6.8 million.
Cash and cash equivalents at quarter-end: $21.9 million, down from $26.6 million at year-end 2024.
Outlook and guidance
Management expects to sustain growth trajectory for PEDMARK® with continued commercial execution and expansion into new markets.
Preliminary results from the Japan STS-J01 clinical trial anticipated in Q4 2025, with potential for registration and partnering opportunities in Japan.
Company believes current funds are sufficient to support planned activities for at least the next twelve months.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Fennec Pharmaceuticals earnings date
Q4 202525 Mar, 2026
Next Fennec Pharmaceuticals earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Fennec Pharmaceuticals Inc. is a specialized biopharmaceutical company primarily focused on developing treatments aimed at preventing ototoxicity (hearing loss) caused by platinum-based chemotherapy in pediatric cancer patients. Its flagship product, PEDMARK, represents a formulation of sodium thiosulfate designed to mitigate this side effect, catering to a niche yet critical aspect of pediatric oncology care. The company is headquartered in Research Triangle Park, North Carolina, and its shares are listed on the Nasdaq.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage